返回 Agenda
How Optimal Regulatory Decision Making Relies on Excellent Regulatory Science
Session Chair(s)
June Raine, MD, MSC, FRCP
Chief Executive
Medicines and Healthcare Products Regulatory Agency (MHRA), United Kingdom
The session will explore how excellent regulatory science is used to support high quality recommendations by regulatory scientific committees. In light of the growing interest in the discipline of regulatory science how can regulatory decision making maximize this opportunity?
Speaker(s)
The New SCiRS initiative – Interaction between Committees and Regulatory Science
Tony Humphreys, MPHARM
European Medicines Agency, Netherlands
Head of the Regulatory Science and Innovation Task Force
Vision for Regulatory Science from the Academic Perspective
Marieke De Bruin, PHARMD, PHD
Utrecht Collaborating Centre for Pharmaceutical Policy and Regulation, Netherlands
Scientific Director
Regulatory Science and Advanced Therapies – An International View
Delphi Coppens, MSC
Utrecht University, Netherlands
PhD Candidate
Vaccines, Biological Medicines and Regulatory Science for Optimal Public Health Decisions
Philip Bryan, PHD
MHRA, United Kingdom
Expert Assessor, Vaccines Biologicals and Advanced Therapies